Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
jYhfKDv5hSj9gtsg